EP3265127

MIFEPRISTONE AND OCTREOTIDE FOR USE IN THE TREATMENT OF CUSHING'S SYNDROME IN A PATIENT HAVING AN ADRENOCORTICOTROPIC HORMONE (ACTH)-SECRETING PANCREATIC NEUROENDOCRINE TUMOR

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    25.2.2016
  • :
    21.2.2024
  • :
    16759295.5
  • :
    24.2.2036
  • :
    MIFEPRISTONE AND OCTREOTIDE FOR USE IN THE TREATMENT OF CUSHING'S SYNDROME IN A PATIENT HAVING AN ADRENOCORTICOTROPIC HORMONE (ACTH)-SECRETING PANCREATIC NEUROENDOCRINE TUMOR

25.2.2016
21.2.2024
  • :
    Corcept Therapeutics, Inc.
  • :
    149 Commonwealth Drive, Menlo Park CA 94025, US
  • :
    MORAITIS, Andreas G.
  • :
    Menlo Park, California 94025, US
  • :
    BELANOFF, Joseph K.
  • :
    Menlo Park, California 94025, US
  • :
    201562127153 P
  • :
    2.3.2015
  • :
    US
  • :
    US2016019646
  • :
    25.2.2016
  • :
    A61K 45/06, C07D 413/06, A61P 35/00, A61K 38/06, A61K 38/12, A61K 51/08, A61K 31/437, A61K 31/4745, A61K 31/505, A61K 31/513, A61K 31/567, A61P 3/10, A61K 38/08